The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Vicky.Marshall@glasgow.ac.uk
3rd floor Neurology, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 2TF
Gandhi, S. E. et al. (2024) Motor complications in Parkinson's disease: results from 3343 patients followed for up to 12 years. Movement Disorders Clinical Practice, 11(6), pp. 686-697. (doi: 10.1002/mdc3.14044) (PMID:38587023)
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Successful Antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT. Movement Disorders, 21(12), pp. 2247-2250. (doi: 10.1002/mds.21159) (PMID:17078059)
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nuclear Medicine Communications, 27(12), pp. 933-937. (doi: 10.1097/01.mnm.0000243374.11260.5b)
Marshall, V. and Grosset, D. (2005) Reply: the meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease. Movement Disorders, p. 118. (doi: 10.1002/mds.20313)
Marshall, V. and Grosset, D. (2003) Role of dopamine transporter imaging in routine clinical practice. Movement Disorders, 18(12), pp. 1415-1423. (doi: 10.1002/mds.10592) (PMID:14673877)
Marshall, V. and Grosset, D. G. (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Movement Disorders, 18(S7), S22-S27. (doi: 10.1002/mds.10574) (PMID:14531042)
Marshall, V.L. and Grosset, D.G. (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology, 61(6), p. 871. (doi: 10.1212/WNL.61.6.871) (PMID:14504352)
Gandhi, S. E. et al. (2024) Motor complications in Parkinson's disease: results from 3343 patients followed for up to 12 years. Movement Disorders Clinical Practice, 11(6), pp. 686-697. (doi: 10.1002/mdc3.14044) (PMID:38587023)
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Successful Antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT. Movement Disorders, 21(12), pp. 2247-2250. (doi: 10.1002/mds.21159) (PMID:17078059)
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nuclear Medicine Communications, 27(12), pp. 933-937. (doi: 10.1097/01.mnm.0000243374.11260.5b)
Marshall, V. and Grosset, D. (2005) Reply: the meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease. Movement Disorders, p. 118. (doi: 10.1002/mds.20313)
Marshall, V. and Grosset, D. (2003) Role of dopamine transporter imaging in routine clinical practice. Movement Disorders, 18(12), pp. 1415-1423. (doi: 10.1002/mds.10592) (PMID:14673877)
Marshall, V. and Grosset, D. G. (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Movement Disorders, 18(S7), S22-S27. (doi: 10.1002/mds.10574) (PMID:14531042)
Marshall, V.L. and Grosset, D.G. (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology, 61(6), p. 871. (doi: 10.1212/WNL.61.6.871) (PMID:14504352)